Sumati Gupta, MD
Geriatric Medicine · Salt Lake City, UTNPI 1003906603
Payments from drug & device makers
Across 319 payments — averaging $6041.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$699K
- AstraZeneca$475K
- Seagen Inc.$216K
- Novartis$214K
- Incyte Corporation$183K
- Clovis Oncology, Inc.$74K
- plus $68K from 6 others
Across 8 payments — averaging $504.73 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Astellas Pharma Global Development$4K
What the payments were for
- Speaking & faculty fees$72477%
- Food & beverage$334%
- Education$18420%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 57 | $698,694 |
| AstraZeneca | 7 | $474,573 |
| Seagen Inc. | 36 | $215,732 |
| Novartis | 5 | $214,224 |
| Incyte Corporation | 185 | $182,743 |
| Clovis Oncology, Inc. | 18 | $73,770 |
| Merck | 4 | $59,956 |
| Acrotech Biopharma Inc. | 3 | $6,854 |
| F. Hoffmann-la Roche AG | 1 | $724 |
| AVEO Pharmaceuticals, Inc. | 1 | $85 |
| Adaptive Biotechnologies Corporation | 1 | $21 |
| Medtronic | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TECENTRIQ$724
How this compares
Too few geriatric medicine providers in Utahto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| WeliregBelzutifan | 28 | $666,408 |
| InlytaAxitinib | 11 | $230,519 |
| XtandiEnzalutamide | 24 | $157,932 |
| OrgovyxRelugolix | 26 | $65,591 |
| EliquisApixaban | 18 | $21,175 |
| Abiraterone Acetate | 29 | $18,599 |
| Prochlorperazine Maleate | 25 | $417 |
| Prednisone | 52 | $269 |
| Levothyroxine Sodium | 25 | $230 |
| Potassium Chloride | 12 | $128 |
| Ondansetron Hcl | 15 | $122 |
| Amlodipine Besylate | 18 | $118 |
| Omeprazole | 14 | $85 |
| Olanzapine | 13 | $83 |
| Famotidine | 12 | $81 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckWelireg | $59,956 | $666,40828 claims |
| PfizerInlyta, Eliquis | $698,694 | $251,69329 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few geriatric medicine providers in Utahon file to place this against a meaningful peer group, so we don't.
Other geriatric medicine in Salt Lake City
- Alison SchlismanSalt Lake City$2K
- Danesh RahimiSalt Lake City$2K
- Ronak IqbalSalt Lake City$1K
- Nicholas BreningSalt Lake City$930
- Cynthia LawlorSalt Lake City$150
- Shaun ChatelainSalt Lake City$37
- Natalie SandersSalt Lake City$0
- Cecilia DaviesSalt Lake City$0
- Kristin HueftleSalt Lake City$0
- Megan PuckettSalt Lake City$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.